Analysis

The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...

With a current absence of company-specific news for Lottery.com, investor attention has shifted to the broader market environment for digital...

A notable shift in sentiment is emerging around Meridian Bank. Market data reveals a substantial surge in short selling activity...

The clinical development pipeline at Avenue Therapeutics is progressing, with recent strategic moves placing several drug candidates in the spotlight....

Shares of defense contractor AeroVironment experienced extreme volatility last week, culminating in a sharp sell-off that has left investors anxious....

The consumer goods titan Procter & Gamble has laid out an ambitious capital return program for its 2026 fiscal year,...

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

While its share price remains significantly depressed from its July 2025 peak, Strategy is adopting a notably aggressive posture. The...

In an unusually broad product launch outside its traditional September cycle, Apple has initiated its most extensive hardware offensive of...

The investment community is closely monitoring Outlook Therapeutics as it navigates a decisive period for its flagship ophthalmic drug. While...